y 27632 has been researched along with Cardiovascular Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Islam, MZ; Miyamoto, A; Shiraishi, M; Van Dao, C | 1 |
| Shi, J; Wei, L | 1 |
| Chen, YH; Longo, FM; Lu, Q; Massa, SM; Zhou, H | 1 |
| Shi, J; Surma, M; Wei, L | 1 |
| Duan, WG; Liao, H; Yan, M; Yuan, ST; Zhang, LY | 1 |
| Egashira, K; Inoue, S; Kaibuchi, K; Kataoka, C; Kitamoto, S; Koyanagi, M; Ni, W; Shimokawa, H; Takemoto, M; Takeshita, A; Usui, M | 1 |
| Shimokawa, H | 1 |
4 review(s) available for y 27632 and Cardiovascular Diseases
| Article | Year |
|---|---|
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Drug Design; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Signal Transduction | 2013 |
Rho kinase as a therapeutic target in cardiovascular disease.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Apoptosis; Cardiovascular Diseases; Coronary Artery Disease; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Heart Failure; Humans; Male; Myocytes, Cardiac; Protein Isoforms; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Vasodilation | 2011 |
[Advances in the study of Rho kinase and its inhibitors].
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Antihypertensive Agents; Cardiovascular Diseases; Humans; Pyridines; rho-Associated Kinases; Signal Transduction; Subarachnoid Hemorrhage; Vasodilator Agents | 2007 |
Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Cardiovascular Diseases; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Humans; Intracellular Signaling Peptides and Proteins; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases; Signal Transduction; Vasodilator Agents | 2002 |
3 other study(ies) available for y 27632 and Cardiovascular Diseases
| Article | Year |
|---|---|
Rho-kinase and the nitric oxide pathway modulate basilar arterial reactivity to acetylcholine and angiotensin II in streptozotocin-induced diabetic mice.
Topics: Acetylcholine; Amides; Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; rho-Associated Kinases; Streptozocin; Time Factors | 2017 |
Signaling through Rho GTPase pathway as viable drug target.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Aminoquinolines; Anilides; Animals; Benzamides; Cardiovascular Diseases; Humans; Lung Diseases; Neoplasms; Nervous System Diseases; Protein Kinase Inhibitors; Pyridines; Pyrimidines; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction | 2009 |
Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
Topics: Actins; Amides; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Chemokine CCL2; Coronary Vessels; Enzyme Inhibitors; Hydralazine; Immunohistochemistry; Inflammation; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Muscle, Smooth; Myosins; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred WKY; rho-Associated Kinases; RNA, Messenger; Superoxide Dismutase; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |